TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
EXEL

Exelixis Inc

Healthcare · Biotechnology

58.90$ +0.8% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Exelixis Inc (EXEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,494 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EXEL
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
548 598 587 517 610 655 775 911 1,024 1,422 1,542 1,643 1,785 1,886 1,956 2,047 2,111 2,137 2,191 2,367 2,448 2,616 2,654 2,881 2,961 3,071 3,143 3,142 2,977 2,942 2,804 2,773 2,960 2,948 2,837 2,678 2,824 2,844 2,594 2,494
421 471 468 402 471 485 566 686 787 897 946 957 972 1,011 1,137 1,395 1,408 1,445 1,434 1,593 1,662 1,835 1,843 1,852 1,842 1,619 1,638 1,591 1,443 1,318 1,292 1,477 1,550 1,468 1,397 1,181 1,402 1,443 1,209 1,251
111 152 183 135 149 183 232 248 354 315 374 370 242 267 357 527 334 319 370 492 567 647 723 627 675 501 541 464 397 263 260 198 258 217 184 164 376 482 226 281
320 420 424 349 367 388 427 500 635 693 800 822 761 852 954 1,213 1,188 1,207 1,185 1,347 1,403 1,467 1,570 1,535 1,547 1,308 1,313 1,267 1,103 995 963 1,002 1,189 1,111 1,031 791 989 1,059 777 839
91 42 34 43 90 81 124 167 129 163 122 110 184 119 137 121 166 161 181 185 182 286 191 239 220 215 234 233 248 237 241 397 270 265 282 292 310 287 329 335
3.3 3.3 3.3 5.4 5.8 6.7 7.6 8.4 10 9.8 10 12 13 13 15 17 19 21 25 25 28 27 28 33 27 33 30 29 25 17 21 21 21 22 25 23 27 22 27 29
2.1 2.6 19 19 26 45 65 51 51 51 67 67 91 48 – 52 110 67 95 100 149 106 109 108 108 111 116 115 374 – – – – – – – – – – –
64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64 64
64 64 64 64 64 64 64 64 – – – – – – – – – – 64 – – – – – – – – – – – – – – – – – – – – –
516 508 467 368 371 370 105 136 108 135 157 154 181 200 208 213 259 258 279 324 335 406 360 490 470 583 588 615 629 678 676 653 685 703 706 645 663 683 658 650
202 271 202 98 109 115 85 100 91 105 125 111 141 143 140 143 201 205 213 255 270 338 289 305 302 324 328 340 377 394 373 346 394 404 399 336 374 406 371 362
109 193 113 38 45 57 53 57 64 2.7 73 73 71 2.7 79 86 109 – 133 162 181 5.1 8.0 – – 18 – 196 7.0 26 4.1 – -3.3 25 – – – – – –
4.0 6.6 4.6 7.0 6.0 9.6 11 13 8.7 11 9.7 12 8.4 12 15 9.1 48 24 14 20 24 24 17 20 31 33 33 26 26 34 26 29 59 38 43 26 25 30 24 39
0.0 0.0 0.0 0.0 0.4 0.0 21 13 12 20 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
32 89 120 149 239 285 670 775 916 1,287 1,385 1,489 1,604 1,686 1,748 1,833 1,852 1,879 1,911 2,043 2,112 2,211 2,294 2,391 2,491 2,488 2,555 2,528 2,348 2,264 2,128 2,120 2,275 2,244 2,131 2,034 2,161 2,161 1,936 1,844
-2,018 -1,983 -1,967 -1,949 -1,868 -1,829 -1,455 -1,367 -1,240 -880 -805 -726 -628 -559 -511 -444 -476 -448 -446 -350 -312 -217 -148 -77 -4.1 -34 5.8 11 -126 -173 -259 -200 -90 -99 -163 -220 -106 -77 -216 -263
256 301 310 311 313 313 314 312 312 312 315 315 315 315 316 318 309 320 321 323 322 323 323 325 325 323 326 327 319 313 306 294 291 282 288 284 279 282 267 260

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?